Research Progress on In-stent Restenosis after Drug-eluting Stent Implantation in Patients with Hyperhomocysteinemia
CHEN Haitao
GUO Jiqiang
GAO Yuping
Abstract：This review summarizes the mechanisms, risk factors, and preventive measures of in-stent restenosis, exploring prevention and treatment strategies for in-stent restenosis. In-stent restenosis is caused by multiple factors and should be identified as early as possible, especially identifying high-risk patients. Appropriate stents or balloons should be selected, and percutaneous coronary intervention (PCI) should be performed in a standardized manner. After surgery, various risk factors should be effectively controlled, and relevant drugs should be taken according to guidelines. Individualized surgical and drug treatments can reduce the incidence of in-stent restenosis.
Keywords：hyperhomocysteinemiain-stent restenosisdrug-eluting stent implantationreview
Publication Date：2025-02-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 397-400 )